Major Depressive Disorder (MDD) - Drug Pipeline Landscape, 2022

Major Depressive Disorder (MDD) also known as clinical depression, is a severe mood disorder which causes persistent or extended periods of depressed or low mood, for more than 2 weeks and a loss of interest in activities thus affecting the mood and ability to function in daily life.

To know more about Major Depressive Disorder (MDD), visit - https://www.globalinsightservices.com/reports/major-depressive-disorder-mdd-drug-pipeline-landscape-2022/

The most common causes of Major Depressive Disorder include genetics, trauma, isolation, significant loss, chemical and hormonal imbalances, abnormal brain chemical levels, comorbid medical illness, medicinal side effects.

Symptoms include sleep disturbances, stress, lack of energy, changes in appetite, unintentional weight loss or gain, poor concentrating, persistently low or depressed mood, anhedonia or decreased interest in pleasurable activities, feelings of guilt or worthlessness, psychomotor retardation or agitation or suicidal thoughts.

To Remain 'Ahead' Of Your Competitors, Request for A Sample - https://www.globalinsightservices.com/request-sample/GIS31093

Key Players
Abbvie
Alto Neuroscience
Alzamend Neuro
Ancora Bio Inc
Boehringer Ingelheim
Cerevel Therapeutics LLC
Chase Therapeutics Corporation
Clexio Biosciences Ltd
CSPC ZhongQi Pharmaceutical Technology Co Ltd
Cybin IRL Limited
Digestome Therapeutics
Gate Neurosciences Inc

Report Segmentation
Assessment by Stage of Development
Assessment by Companies
Assessment by Target
Assessment by Mechanism of Action
Assessment by Molecule Type
Assessment by Route of Administration

Get Customized Report as Per Your Requirement - https://www.globalinsightservices.com/request-customization/GIS31093

Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.

For In-Depth Competitive Analysis, Purchase this Report - https://www.globalinsightservices.com/inquiry-before-buying/GIS31093

With Global Insight Services, you receive:
• 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Excel data pack included with all report purchases
• Robust and transparent research methodology

Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm
headquartered in Delaware, US. We are committed to providing our clients
with highest quality data, analysis, and tools to meet all their market research
needs. With GIS, you can be assured of the quality of the deliverables, robust
and transparent research methodology, and superior service.

This release was published on openPR.